Security Check

Jinshazhou Hospital of Guangzhou University of Chinese Medicine

Dual NMPA GCP Drug & Device Clinical Trial Institution
Top Specialties
Precision Oncology
Flagship specialty leading national radiosurgery standards.
Orthopedics
Led by President Liu Wensheng, performing over 20,000 minimally invasive surgeries.
TCM Preventive Medicine
Core disciplinary cluster driving comprehensive, holistic health management.
Hospital Introduction
Located in the Baiyun District of Guangzhou, the Jinshazhou Hospital of Guangzhou University of Chinese Medicine is a large, non-profit Grade III General Hospital. Serving as a crucial civic project and master's/doctoral training base, it integrates profound traditional healing with cutting-edge international oncology and precision medicine.
Grade III General Hospital
2 NATCM Key Specialties
5 High-Level Clinical Specialties
Sino-Australian Oncology Center
Book Consultation
Hospital Tier
Tertiary Grade-A
Ownership
Private Hospital
Location
Guangzhou, China
Established
2010
Address
No. 1, Lichuandong Street, Jinshazhou
Jinshazhou Hospital
No. 1, Lichuandong Street
Guangzhou, Guangdong, China
1500 Total Beds (Expanding to 2,000+)
31 Laminar Flow Operating Rooms
68 Minimally Invasive Surgery Rate (%)
5000 Annual ER Critical Cases

Key Insight: The hospital commands over RMB 500 million in advanced medical equipment, including Varian TrueBeam and the MEVION S250i proton therapy system. It guarantees an emergency response time of under 8 minutes for its population catchment of 700,000.

A Convergence of Heritage &
High-Tech Medical Innovation

Jinshazhou Hospital of Guangzhou University of Chinese Medicine integrates three core disciplinary clusters: Precision Oncology, TCM Preventive Medicine (Zhi Wei Bing), and Rehabilitation Medicine. Designed to Tertiary Grade A standards, it is a formidable pillar of the Guangzhou 120 emergency network.

Beyond its comprehensive general services, the hospital distinguishes itself through the International Oncology Medical Center. Supported by a robust Sino-Australian technology partnership and 30+ MDT experts, it delivers global-standard genomic testing and advanced radiotherapeutic interventions.

Host Unit

International Oncology Medical Center (Sino-Australian)

Precision Medicine Center
Comprehensive Oncology Medical Department

Hospital Classification & Innovation

Grade III

Large Non-Profit General Hospital

While not participating in the Fudan Top 100 comprehensive rankings due to its operational structure, the hospital achieves high-level acclaim through its 5 Guangdong Provincial High-Level Key Clinical Specialties and its leading role in national radiosurgery networks.

Institutional Status & External Evidence

Ranking / External Evaluation
Grade III General Hospital
Hospital Classification / Accreditation
NMPA GCP Drug & Device Clinical Trial Institution Guangdong Provincial First-Batch Internet Hospital (2019) ISO 15189 Medical Lab Quality (Self-declared) US CAP Quality Standard (Self-declared) CMDA Radiation Oncology Radiosurgery Inaugural Chair Unit

National Key Disciplines & Specialties

Precision Oncology / Radiation Oncology

Flagship specialty leading national radiosurgery standards. Utilizes advanced WES/NGS technologies for tumor diagnostic assays.

Orthopedics

Guangdong Provincial High-Level Key Specialty. Led directly by President Liu Wensheng, excelling in minimally invasive procedures.

Rehabilitation Medicine

One of the hospital's three core disciplinary clusters, deeply integrating TCM modalities with modern rehabilitative protocols.

TCM Preventive Medicine

A cornerstone cluster leveraging the academic resources of GZUCM to deliver holistic chronic disease management.

TCM-Western Medicine Integration

A Provincial High-Level Key Specialty ensuring seamless, evidence-based care across all major clinical departments.

2 NATCM Key Specialties

Holding the highest national designation applicable to non-MOE-affiliated hospitals in traditional Chinese medicine.

Medical & Research Innovation Hubs

CAEH Radiosurgery Training Base (Chair Unit)
CMDA Radiation Oncology Radiosurgery Inaugural Chair Unit
CSCO (Chinese Society of Clinical Oncology) — Vice-Chairman Unit
International Oncology Medical Center (Sino-Australian)
Guangdong Provincial 2nd Smart Peritoneal Dialysis Center
Precision Medicine Center
Guangzhou Intelligent Robot-Assisted Surgery Consultation Center
Minimally Invasive Diagnosis & Treatment Center
Emergency & Critical Care Center
Obesity & Metabolic Disease Treatment Center
Ophthalmology Center
GZUCM Clinical Medical College

Global Oncology & Precision Medicine

While functioning without a separately branded "International Department," the hospital acts as a major international node through its Sino-Australian International Oncology Medical Center. This center channels global expertise to provide unparalleled oncological and precision medicine services.

  • Academic collaboration with the University of Wollongong to develop an integrated medical physics training platform.
  • International MDT panels featuring 30+ expert oncologists covering 15 distinct sub-specialties.
  • Equipped with globally leading technology including the MEVION S250i proton therapy system and Accuray M6 CyberKnife.

Global Excellence Standard

By combining state-of-the-art international hardware with sophisticated, multinational MDT consultations, the hospital ensures world-class, individualized cancer care.

Precision Diagnostics

Performing 20+ advanced tumor diagnostic tests using WES/NGS technologies, matching the highest international diagnostic protocols.

Source & Verification

Hospital entity information on this page is maintained from official institutional and government-level sources reviewed by MedBridge. Departmental services, rankings, certifications, and operational information may change over time and should be confirmed with the institution before making a medical decision.

Primary Institutional Source Jinshazhou Hospital of Guangzhou University of Chinese Medicine — official hospital website.
Government / Official Records Chinese government and official institutional records reviewed as part of the MedBridge audit process.
MedBridge Verification Hospital entity data has been reviewed against the source records maintained by MedBridge.
QA date: October 6, 2026.